<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35871259</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Psychometric properties of the Spanish version of the EuroQol-5D-5L in previously hospitalized COVID-19 survivors with long COVID.</ArticleTitle><Pagination><StartPage>12605</StartPage><MedlinePgn>12605</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12605</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-17033-1</ELocationID><Abstract><AbstractText>The EuroQol 5-dimensions 5-levels (EQ-5D-5L) is a generic patient-reported outcome measures (PROM) used for evaluating health-related quality of life (HRQoL). No data on its psychometric properties in COVID-19 survivors is available. We aimed to describe internal consistency, test-retest reliability, and construct validity of the EQ-5D-5L in people with long-COVID. Ninety-three (n&#x2009;=&#x2009;93) individuals previously hospitalized due to COVID-19 with post-COVID symptoms completed the EQ-5D-5L questionnaire twice one year after hospital discharge in a three-week interval. Internal consistency (Cronbach alpha and Omega value), test-retest reliability (kappa and ICC<sub>2,1</sub>) and construct validity (factor analysis), and floor/ceiling effects were calculated. No ceiling effect was observed in any dimension whereas the floor effect ranged from 53.76 to 94.62%. The overall Cronbach's &#x3b1; value was 0.75 (95%CI 0.64-0.83) and the Omega &#x3c9; value was 0.77 (95%CI 0.66-0.84), showing good internal consistency of the questionnaire. Further, Cronbach's alpha values the of each dimension ranged from 0.63 to 0.77 whereas those for Omega values ranged from 0.70 to 0.79. The test-retest reliability of the total score was excellent (ICC<sub>2,1</sub> 0.86, 95%CI 0.798-0.911). The agreement percentage ranged from 85.13 to 96.77%; but kappa coefficients ranged from fair (&#x3ba;: 0.37) to good (&#x3ba;: 0.61). The factor analysis showed factor loadings from 0.585 to 0.813 supporting good construct validity. The EQ-5D-5L has good psychometric properties to be used as a PROM to assess HRQoL in hospitalized COVID-19 survivors with long-COVID.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-de-Las-Pe&#xf1;as</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos (URJC), Avenida de Atenas s/n, Alcorc&#xf3;n, 28922, Madrid, Spain. cesar.fernandez@urjc.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Jim&#xe9;nez</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos (URJC), Avenida de Atenas s/n, Alcorc&#xf3;n, 28922, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moro-L&#xf3;pez-Menchero</LastName><ForeName>Paloma</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos (URJC), Avenida de Atenas s/n, Alcorc&#xf3;n, 28922, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cancela-Cilleruelo</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos (URJC), Avenida de Atenas s/n, Alcorc&#xf3;n, 28922, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pardo-Hern&#xe1;ndez</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Consejer&#xed;a de Salud P&#xfa;blica, Comunidad de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health and Preventive Medicine, Universidad Rey Juan Carlos (URJC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Barrera</LastName><ForeName>Valent&#xed;n</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Public Health and Preventive Medicine, Universidad Rey Juan Carlos (URJC), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-de-Miguel</LastName><ForeName>&#xc1;ngel</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Department of Public Health and Preventive Medicine, Universidad Rey Juan Carlos (URJC), Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>23</Day><Hour>23</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35871259</ArticleId><ArticleId IdType="pmc">PMC9307967</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-17033-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-17033-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Int. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Amdal CD, et al. Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; A systematic literature review. Qual. Life Res. 2021;30:3367&#x2013;3381. doi: 10.1007/s11136-021-02908-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02908-z</ArticleId><ArticleId IdType="pmc">PMC8214069</ArticleId><ArticleId IdType="pubmed">34146226</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizarro-Pennarolli C, et al. Assessment of activities of daily living in patients post COVID-19: A systematic review. Peer J. 2021;9:e11026. doi: 10.7717/peerj.11026.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.11026</ArticleId><ArticleId IdType="pmc">PMC8034364</ArticleId><ArticleId IdType="pubmed">33868804</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;rlimann O, Decavel P, Annoni JM, Mancinetti M. Return to work after hospitalisation for COVID-19 infection. Eur. J. Intern. Med. 2022;97:110. doi: 10.1016/j.ejim.2022.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2022.01.010</ArticleId><ArticleId IdType="pmc">PMC8743451</ArticleId><ArticleId IdType="pubmed">35031214</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano, J.B., Murthy, S., Marshall, J.C., Relan, P., Diaz, J.V., &amp; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis.22, e102&#x2013;e107 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, et al. The post-COVID-19 functional status (PCFS) scale: A tool to measure functional status over time after COVID-19. Eur. Respir. J. 2020;56:2001494. doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorca, L.A., Le&#xe3;o Ribeiro, I., Torres-Castro, R., Sacomori, C., &amp; Rivera, C. Psychometric properties of the post-COVID 19 functional status scale for adult COVID 19 survivors. Rehabilitacion S0048-7120(21)00074-8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324401</ArticleId><ArticleId IdType="pubmed">34426013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilke S, et al. Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual. Life Outcomes. 2021;19:40. doi: 10.1186/s12955-021-01691-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01691-2</ArticleId><ArticleId IdType="pmc">PMC7856622</ArticleId><ArticleId IdType="pubmed">33536042</ArticleId></ArticleIdList></Reference><Reference><Citation>Pequeno NPF, Cabral NLA, Marchioni DM, Lima SCVC, Lyra CO. Quality of life assessment instruments for adults: A systematic review of population-based studies. Health Qual. Life Outcomes. 2020;18:208. doi: 10.1186/s12955-020-01347-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01347-7</ArticleId><ArticleId IdType="pmc">PMC7329518</ArticleId><ArticleId IdType="pubmed">32605649</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, et al. Development and preliminary testing of the new five-level version of the EQ-5D (EQ-5D-5L) Qual. Life Res. 2011;20:1727&#x2013;1736. doi: 10.1007/s11136-011-9903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen MF, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Qual. Life Res. 2013;22:1717&#x2013;1727. doi: 10.1007/s11136-012-0322-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-012-0322-4</ArticleId><ArticleId IdType="pmc">PMC3764313</ArticleId><ArticleId IdType="pubmed">23184421</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira LN, Pereira LN, da F&#xe9; Br&#xe1;s M, Ilchuk K. Quality of life under the COVID-19 quarantine. Qual. Life Res. 2021;30:1389&#x2013;1405. doi: 10.1007/s11136-020-02724-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-020-02724-x</ArticleId><ArticleId IdType="pmc">PMC7778495</ArticleId><ArticleId IdType="pubmed">33389523</ArticleId></ArticleIdList></Reference><Reference><Citation>Poudel AN, et al. Impact of COVID-19 on health-related quality of life of patients: A structured review. PLoS ONE. 2021;16:e0259164. doi: 10.1371/journal.pone.0259164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259164</ArticleId><ArticleId IdType="pmc">PMC8553121</ArticleId><ArticleId IdType="pubmed">34710173</ArticleId></ArticleIdList></Reference><Reference><Citation>Poteet S, Craig BM. QALYs for COVID-19: A comparison of US EQ-5D-5L value sets. Patient. 2021;14:339&#x2013;345. doi: 10.1007/s40271-021-00509-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40271-021-00509-z</ArticleId><ArticleId IdType="pmc">PMC8007385</ArticleId><ArticleId IdType="pubmed">33782840</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: A systematic review of the literature. Qual Life Res. 2021;30:647&#x2013;673. doi: 10.1007/s11136-020-02688-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-020-02688-y</ArticleId><ArticleId IdType="pmc">PMC7952346</ArticleId><ArticleId IdType="pubmed">33284428</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual. Life Res. 2011;20:1727&#x2013;1736. doi: 10.1007/s11136-011-9903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hout B, et al. Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 2012;15:708&#x2013;715. doi: 10.1016/j.jval.2012.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2012.02.008</ArticleId><ArticleId IdType="pubmed">22867780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez G, et al. Validity of the EQ-5D-5L and reference norms for the Spanish population. Qual. Life Res. 2018;27:2337&#x2013;3234. doi: 10.1007/s11136-018-1877-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-018-1877-5</ArticleId><ArticleId IdType="pubmed">29767329</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Gordillo MA, Adsuar JC, Olivares PR. Normative values of EQ-5D-5L: In a Spanish representative population sample from Spanish Health Survey, 2011. Qual. Life Res. 2016;25:1313&#x2013;1321. doi: 10.1007/s11136-015-1164-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-015-1164-7</ArticleId><ArticleId IdType="pubmed">26482825</ArticleId></ArticleIdList></Reference><Reference><Citation>Terwee CB, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J. Clin. Epidemiol. 2007;60:34&#x2013;42. doi: 10.1016/j.jclinepi.2006.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2006.03.012</ArticleId><ArticleId IdType="pubmed">17161752</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokkink LB, et al. The COSMIN study reached international consensus on taxonomy terminology, and definitions of measurement properties for health-related patient-reported outcomes. J. Clin. Epidemiol. 2010;63:737&#x2013;745. doi: 10.1016/j.jclinepi.2010.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.02.006</ArticleId><ArticleId IdType="pubmed">20494804</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunnally JC, Bernstein IH. Psychometric Theory. 3. McGraw-Hill; 1994.</Citation></Reference><Reference><Citation>Dunn TJ, Baguley T, Brunsden V. From alpha to omega: A practical solution to the pervasive problem of internal consistency estimation. Br. J. Psychol. 2014;105:399&#x2013;412. doi: 10.1111/bjop.12046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjop.12046</ArticleId><ArticleId IdType="pubmed">24844115</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis J, Koch G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977;33:363&#x2013;374. doi: 10.2307/2529786.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2529786</ArticleId><ArticleId IdType="pubmed">884196</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J. Chiropr. Med. 2016;15:155&#x2013;163. doi: 10.1016/j.jcm.2016.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcm.2016.02.012</ArticleId><ArticleId IdType="pmc">PMC4913118</ArticleId><ArticleId IdType="pubmed">27330520</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayuso Garc&#xed;a B, et al. [Health-related quality of life in patients recovered from COVID-19] J. Health Qual. Res. 2022;7:208&#x2013;215. doi: 10.1016/j.jhqr.2022.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhqr.2022.01.001</ArticleId><ArticleId IdType="pmc">PMC8761545</ArticleId><ArticleId IdType="pubmed">35125340</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, et al. Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2020;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, et al. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC9181377</ArticleId><ArticleId IdType="pubmed">35683388</ArticleId></ArticleIdList></Reference><Reference><Citation>Egede, L.E. et al. Short-term impact of COVID-19 on quality of life, perceived stress, and serious psychological distress in an adult population in the mid-west United States. Qual. Life Res.10.1007/s11136-022-03081-7 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8753941</ArticleId><ArticleId IdType="pubmed">35020111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamberini L, et al. Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up. Qual. Life Res. 2021;30:2805&#x2013;2817. doi: 10.1007/s11136-021-02865-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02865-7</ArticleId><ArticleId IdType="pmc">PMC8113006</ArticleId><ArticleId IdType="pubmed">33977415</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, et al. Factors associated with impaired quality of life three months after being diagnosed with COVID-19. Qual. Life Res. 2021;28:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8476326</ArticleId><ArticleId IdType="pubmed">34580823</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegde, S., Sreeram, S., Bhat, K.R., Satish, V., Shekar, S., &amp; Babu, M. Evaluation of post-COVID health status using the EuroQol-5D-5L scale. Pathog. Glob. Health7, 1&#x2013;11. 10.1080/20477724.2022.2035623 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9639560</ArticleId><ArticleId IdType="pubmed">35129097</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>